Fecal microbiota transplantation (FMT) from humans to mice demonstrated that anti-CTLA-4 antibody treatment in melanoma patients promotes the expansion of Bacteroides fragilis, which possesses potent anticancer properties [11]. Here, CTLA4 is linked to melanoma.